Target intelligence / Profile preview

Other amino acid transport systems

Molecular classification
Transporter, Solute carrier family
01

Overview

Other amino acid transport systems refers to a heterogeneous group of membrane transport proteins, primarily within the Solute Carrier (SLC) superfamily, that mediate the uptake and efflux of amino acids across cellular and organelle membranes. This classification typically includes systems such as System A (SLC38 family), System L (SLC7 family), System N, and System ASC, which are distinguished by their substrate preferences, ion dependencies, and transport mechanism (Alexander et al., 2021). These transporters are fundamental to cellular physiology, as they provide the necessary precursors for protein synthesis, maintain osmotic balance, and regulate metabolic signaling pathways such as the mechanistic target of rapamycin (mTOR) (Bröer, 2008). In various diseases, particularly cancer, these transporters are frequently dysregulated; for instance, the L-type amino acid transporter 1 (LAT1/SLC7A5) is often overexpressed in malignant cells to sustain rapid growth and proliferation (Kandasamy et al., 2018). Consequently, these systems are significant therapeutic targets, either through direct inhibition to starve tumor cells or by exploiting them as 'Trojan horses' for the delivery of amino acid-mimetic drugs like melphalan and levodopa (Häfliger & Charles, 2019). Mutations in these transport systems are also associated with hereditary conditions such as Hartnup disease and cystinuria, highlighting their critical role in systemic amino acid homeostasis.

Other names
Amino acid transportersSolute carrier amino acid transportersSLC transportersSystem ASystem LSystem NSystem ASC
02

Mechanism of action

Competitive inhibition of amino acid transport or utilization as a transport vehicle for prodrug delivery.

03

Biological functions

Amino acid transportNutrient uptakeMetabolic regulationNeurotransmitter transport
04

Disease associations

CancerMetabolic disordersNeurological diseaseAminoaciduria
05

Safety considerations

Disruption of essential amino acid homeostasisPotential neurotoxicityOff-target effects on systemic metabolismCompetition with endogenous nutrients
06

Interacting drugs

Gabapentin

8 more in the full profile.

07

Biomarkers

LAT1 (SLC7A5) expressionASCT2 (SLC1A5) expression18F-FET PET imaging11C-Methionine PET imaging

Beyond the preview

Go deeper on Other amino acid transport systems.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Other amino acid transport systems.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call